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1. Introduction 
Over the years the disease known as primary hyperparathyroidism has undergone a 
dramatic change in the clinical spectrum ranging from a symptomatic disease to an 
asymptomatic disease. In spite of the current understanding of the disease perspective, the 
mainstay of treatment is still surgical.  
The standard treatment advocated and practiced for years could be considered as a source 
control operation involving routine bilateral exploration of the neck with an attempt to 
identify and eliminate the offending gland or glands. These surgeries were elaborate, time 
consuming and the success rates depended on the experience of the surgeon. Of late, 
certain novel and more patient-friendly techniques such as minimally invasive surgery 
and targeted selective gland excision are being performed with reportedly excellent 
outcomes.  
This chapter reviews and discusses the surgical aspects of parathyroid surgery including the 
evolution of surgery from the ‘conventional bilateral cervical exploration’ to recent advances 
such as ‘minimally invasive surgery’ and ‘focused parathyroidectomy’. The clinical features 
of primary hyperparathyroidism and indications for parathyroidectomy are also described, 
followed by a review of surgical techniques currently being practiced. 
2. Anatomy 
2.1 The surgical anatomy of the parathyroid glands 
A good surgeon should also be an excellent anatomist. The ultimate triumph of the surgical 
management of primary hyperparathyroidism is often based on the surgeon’s knowledge of 
the normal anatomical relationships and more so about the important embryologic 
variations of the parathyroid anatomy.  
Practically everyone has at least four parathyroid glands, but their number can vary 
between 2 to 6. [Figure 1]. Thus in about 80% of cases there are symmetrically four (2 on 
either side) and in 5-13% of the cases they may be supernumerary (Hooghe et al., 1992). For 
example, in an autopsy study of 503 cases, in 84% there were four glands, 3% of the cases 
had only three glands, and in 13% there were supernumerary glands. The supernumerary 
gland was often a fifth gland tucked away in the thymus (Akerström et al., 1984).  
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The parathyroid glands are oval shaped, well encapsulated and smooth, often the size of a 
split pea, and yellow, pink or tan in colour weighing around 20-40 mg each. Normal 
parathyroid glands measure approximately 6 mm in length, 3–4 mm in transverse diameter, 
and 1–2 mm in anteroposterior diameter. In addition to the yellowish tinge, these small 
glands are often camouflaged by a covering of fat making it difficult to identify them during 
surgery and may be confused with surrounding fat. The parathyroid gland usually weighs 
around 29.5 mg ± 17.8 (mean ± standard deviation), with a reported upper limit of 65 mg 
(Dufour & Wilkerson, 1983). However, the weight of the normal parathyroid glands 
removed at surgery in patients with primary hyperparathyroidism may be greater than that 
reported in autopsy studies (Yao et al., 2004).  
 
Fig. 1. The normal location of paired parathyroids and a supernumerary fifth gland within 
the thymus. 
The inferior parathyroid gland derives its blood supply from the inferior thyroid artery. In 
about 10% of patients, the inferior thyroid artery may be absent, in which case the superior 
thyroid artery supplies the inferior parathyroids (Delattre et al, 1982). The superior 
parathyroid gland is also usually supplied by the inferior thyroid artery or from an 
anatomizing artery joining the superior and inferior parathyroid arteries. In about 20-45% of 
cases, the superior parathyroid glands receive their blood supply from a posterior branch of 
the superior thyroid artery (Bonjer & Bruining, 1997; Nobori et al., 1994). There often exists a 
good collateral arterial supply from the tracheal vessels and therefore adequate parathyroid 
function persists even if all four major thyroid arteries are ligated. 
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About 15-19 % of the glands can be found in ectopic locations and distant from the 
thyroid lobes, mostly posterior alongside the esophagus, in the upper anterior 
mediastinum encapsulated in the thymus, and within the carotid sheath or even rarely 
(0.5-4%) embedded within the thyroid itself. (Wang, 1981; Feliciano, 1992). The ectopic or 
aberrant locations of the parathyroid gland are related to discrepancies during 
embryological development and descent. 
Key points-1 
 In 80% of cases parathyroids are normal in position, symmetrical and paired. 
 About 20% of the parathyroids are ectopic.  
 65mg is the upper normal weight limit for a single gland. 
 Supernumerary glands may be commonly found within thymus (“para-thymus”). 
 Collateral blood supply from tracheal vessels is protective to the parathyroids. 
 Intra-thyroidal location of the parathyroid is rare. 
2.2 Applied surgical embryology of the parathyroids 
Although functionally independent, the development of thyroid, parathyroid and the 
thymus are closely related to one another. The parathyroid glands develop from the 
cranial portions of the third and fourth pharyngeal (branchial) pouches on either side of 
the embryo and are therefore designated as parathyroid glands III and parathyroid glands IV 
respectively. Since these pouches are bilateral they should normally yield four 
parathyroid glands. 
The parathyroid III (the future inferior parathyroids) and the thymus arise from the third 
branchial pouch from its dorsal and ventral wings respectively [figure2]. The downward 
descent of the thymus pulls the parathyroid III along with it. But parathyroids usually halt 
at the dorsal surface and outside the fibrous capsule of the thyroid gland while the thymus 
descends further beyond. This embryonic descent therefore places the parathyroid IIIs 
inferior to the parathyroid IVs in the neck, thereby designating them as inferior and superior 
parathyroids respectively. Discrepancies in this course of normal descent can cause the 
parathyroid IIIs to be situated at levels higher up in the neck (sometimes referred to as 
‘undescended parathymus’). 
The parathyroid IV glands (the future superior parathyroids) and the ultimobranchial 
bodies are derived from the fourth pharyngeal pouch and migrate together. The superior 
parathyroid glands travel with the ultimobranchial bodies and consequently migrate a 
shorter distance than the inferior glands. They therefore remain in contact with the posterior 
part of the middle third of the thyroid lobes and are in a comparatively more constant 
position in the neck. 
Key points-2 
 The superior parathyroids are more constant in location. 
 The inferior parathyroids are more prone to become ectopic. 
 The superior parathyroid glands are typically located about 1 cm superior to the 
intersection of the inferior thyroid artery and the recurrent laryngeal nerve.[ along the 
posterior border of the thyroid]. 
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 The inferior glands are commonly found near the lower pole of the thyroid more often 
in an anterior plane. 
 
Fig. 2. The developing branchial complex demonstrating the parathyroid III (P3) and 
thymus (T) budding from the third branchial pouch on the dorsal and ventral aspects 
respectively. Pathways of parathyroids III (P3) and IV (P4) denoted by arrows. 
3. Primary hyperparathyroidism 
Primary hyperparathyroidism (PHPT) is a hypercalcaemic state caused by excessive 
unregulated production of parathyroid hormone, resulting in defective calcium 
homeostasis. The secretion of parathyroid hormone is regulated directly by the plasma 
concentration of ionized calcium. The exact cause of spontaneous hyperfuctioning of the 
parathyroids is unknown and it is often recognized due to peripheral or systemic effects of 
the excess hormone. 
PHPT can be regarded as a relatively recent disease owing to the fact that the parathyroid 
glands were the last major organ to be recognized in humans. (Elaraj & Clark, 2008). Ivar 
Sandström, a Swedish medical student, in 1879 was the first to describe the parathyroid 
glands. (Eknoyan, 1995) 
3.1 The spectrum of parathyroid disease 
Parathyroid disease usually manifests in three forms namely primary, secondary and 
tertiary hyperparathyroidism. Primary hyperparathyroidism (PHPT) is a relatively 
common endocrine disorder and is the commonest reason for surgical exploration. The 
other two forms are consequences of other disease processes. 
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TYPE CAUSE TREATMENT 
Primary HPT 
Unregulated overproduction of 
parathyroid hormone resulting in 
abnormal calcium homeostasis, due to 
adenoma, hyperplasia or carcinoma, 
familial syndromes(MEN 1 or MEN 2a), 
familial isolated hyperparathyroidism 
(FIHPT) etc. 




Excessive production of parathyroid 
hormone secondary to a chronic 
abnormal stimulus such as chronic renal 
failure and vitamin D deficiency. 
Primarily 
medical management  
Tertiary HPT 
Autonomous hypersecretion of 
parathyroid hormone causing 
hyperalcaemia often seen in chronic 
secondary hyperparathyroidism 
(prolonged compensatory stimulation) 
and often after renal transplantation. 
Total parathyroidectomy 
with auto transplantation, 
subtotal 
parathyroidectomy  
Table 1. The spectrum of hyperparathyroidism 
3.2 Incidence 
There is a wide variation in the incidence of PHPT geographically. This variation is most 
markedly seen in between the western world and developing countries. It is a common 
endocrine disease in countries where hyperalcaemia is detected at an early stage due to 
routine biochemical screening (Bilezikian et al, 2002). The exact incidence of PHPT is difficult 
to define since many patients remain asymptomatic and the reported incidence varies 
according to the population studied. In the United States, the incidence of primary 
hyperparathyroidism is 2 to 3 per 1000 women and approximately 1 per 1000 men. The 
incidence increases to 2% after the age of 55 years. It is more commonly seen in 
postmenopausal woman older than 50 years. With the advent of multichannel biochemical 
screening in the 1970s, the incidence of PHPT increased around the world especially in 
western countries and this brought to light the existence of the entity referred to as 
‘asymptomatic PHPT’. 
3.3 Etiopathogenesis  
The exact cause of primary hyperparathyroidism is not clear and may possibly due to an 
underlying primary pathology of the parathyroid gland itself.The pathogenesis of PHPT may 
be sporadic or familial. Normally the parathyroid glands are composed of chief cells, oxyphil 
cells, and transitional oxyphil cells mixed with adipose tissue. Chief cells secrete parathyroid 
hormone. Sporadic PHPT involves abnormal tissue in the parathyroid gland [figure 3]. 
The pathological lesions responsible for PHPT include solitary adenomas (>80%); double 
adenomas (2–3%) multigland hyperplasia (15%) and carcinoma (1-2%).(Kaplan et al,1992) 
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Inherited disorders include familial hyperparathyroidism, multiple endocrine neoplasia 
syndrome (MEN type 1 and 2A), and hyperparathyroidism-jaw tumor syndrome and these 
account for roughly about 10% of PHPT. Other suggested causes include over expression of 
PRAD1 oncogene and also low dose irradiation to the neck during childhood. 
3.4 Double parathyroid adenomas -“fact or fiction”? 
Double parathyroid adenomas account for only a small percentage of the lesions associated 
with PHPT. Controversy still exists as to whether double adenomas are a distinct entity or 
part of four gland hyperplasia presenting metasynchronously. There is no reliable method 
to accurately distinguish adenoma from hyperplasia. Some authors feel that the most reliable 
clinical criteria to document double adenomas, is the absence of recurrent hyperparathyroidism 
on follow up of at least 5 years following selective gland excision (Baloch & LiVolsi., 2001). 
Meanwhile some others have authoritatively documented the existence of double adenoma 
as a separate entity and are not simply missed cases of four-gland hyperplasia. (Abboud et 
al., 2005). Neonatal convulsions as the initial presentation of maternal PHPT due to double 
parathyroid adenomas has also been described (Zachariah & Thomas, 2010). 
 
Fig. 3. Photomicrograph of a solitary parathyroid adenoma showing hypercellular 
parathyroid tissue, absence of fat cells and surrounding capsule (Haematoxylin & Eosin *40) 
3.5 Clinical features 
It is now well known or well phrased that “The clinical presentation of PHPT has changed from 
a symptomatic to an asymptomatic disease”. Patients with severe symptoms have become 
exceedingly rare. To make the discussion simpler, PHPT can be broadly classified into two 
types-namely symptomatic and asymptomatic PHPT, a view also supported by a National 
Institutes of Health consensus panel. (Bilezikian et al., 2002; Kearns & Thompson, 2002) 
Clinical features are associated to the direct and indirect effects of excess parathyroid 
hormone on the skeleton, kidneys, and intestine may include bone resorption of calcium and 
phosphorus, enhanced intestinal absorption of calcium, renal tubular reabsorption of 
calcium, and hypercalciuria 
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3.5.1 Asymptomatic PHPT 
Asymptomatic PHPT (APHPT) is the commonest form of the disease and therefore the most 
common clinical presentation of primary hyperparathyroidism is asymptomatic 
hyperalcaemia and this accounts for 75% to 80% of cases. However it should be understood 
that absence of any of the obvious classical clinical presentations is what is commonly 
referred to as asymptomatic disease. In such patients the symptoms are mild and 
nonspecific, often underestimated. But studies have shown that the so called asymptomatic 
patients will often have symptoms or metabolic complications when carefully evaluated 
with standardized health questionnaires. (Burney et al., 1999; Talpos et al., 2000). Patients 
may have weakness, fatigue, mild depression, anorexia, and often increased absence from 
work. These patients have mild and sometimes only intermittent hypercalcemia. In most of 
these cases, the mean serum calcium concentration is less than 1.0 mg/dL (0.25 mmol/L). 
Truly asymptomatic PHPT is therefore rare, occurring in only 2% to 5% of patients. (Chan et 
al, 1995; Clark et al, 1991) The importance of APHPT is that the surgical management of 
asymptomatic patients has been controversial and this very aspect has encouraged the 
formulation of treatment guidelines. 
3.5.2 Symptomatic PHPT 
This was the original form of the disease and is still at large in developing countries. The 
signs and symptoms of hyperparathyroidism largely reflect the effects of hypercalcemia and 
may involve multiple organ systems (Taniegra, 2004). 
Classical symptoms of PHPT popularly summed up as “bones, stones, abdominal groans and 
psychic moans” are hardly ever encountered today. (Silverberg et al, 1999) This may be true 
in the western world. Conversely, in developing countries classic and severe forms of the 
disease are still the presenting features and asymptomatic PHPT is probably a rarity. Some 
of the classical radiological findings are shown in figure 4. 
Bone related problems were the first to call attention to the disease and include 
manifestations of selective cortical bone loss. The high incidence of bone disease in patients 
with PHPT in developing countries has been attributed to associated vitamin D and dietary 
calcium deficiency (Harinarayan, 1995). The various classical clinical features are summed 
up in [Table 2]. Cardiovascular manifestations include hypertension, bradycardia, shortened 
QT interval, and left ventricular hypertrophy. It should be remembered that the symptoms 
may not be proportional to magnitude of hypercalcaemia. 
In developing countries the scenario and spectrum of the disease are therefore different. In a 
systematic review of data of 858 patients with PHPT, from India, showed that majority of 
the patients (71.5%) were less than 40 yrs of age, (whereas patients from developed nations 
are diagnosed in the fifth and sixth decades) (Pradeep et al, 2011). Interestingly, 5 to 33% 
had a clinically palpable parathyroid gland. Also, the incidence of parathyroid carcinoma 
causing PHPT in the various series has been 2.6 to 6%, which is higher than in developing 
countries. Moreover in India, asymptomatic presentation is virtually unheard of. The 
symptomatic disease is identified much later after a series of management for fractures and 
renal stones. Another study also showed similar results, where in, 67% had bone disease, 
48% had fractures, 21% had stone disease, 23% had psychiatric symptoms and 15% had 
peptic ulcer disease (Bhansali et al, 2005). 
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Fig. 4. SYMPTOMATIC PHPT: (A) Xray of the hands showing subperiosteal bone resorption 
over the middle phalanges (white arrows). (B) Showing “salt and pepper” appearance of the 








Bone & Joint Pain;  
Osteoclastic Bone Resorption,Pseudo-gout;  
Chondrocalcinosis;Brown tumour, Bone 
cysts 
Stones Renal 
Polyuria; Haematuria; Graveluria; 
Recurrent urinary tract infections 
Nephrolithiasis (35-50%); Nephrocalcinosis 
(rare: 3-5%) 
Hypercalciuria 
Abdominal Groans Gastro-Intestinal  
Anorexia;Vomiting;Abdominal 






Depression; Poor Libido;  
Memory Loss,Lack of concentration 
Table 2. Clincal features of classical disease 
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The association between pancreatitis and hyperparathyroidism was first reported in 1940 by 
Smith and Cooke. (Bess et al, 1980). The commonest manifestation of pancreatic disease with 
PHPT is the history of recurrent upper abdominal pain. A high concentration of serum 
calcium may responsible for the increased incidence of gall stone disease in PHPT and this is 
seen especially in developing countries 
4. Making the diagnosis of primary hyperparathyroidism 
4.1 Laboratory diagnosis 
The diagnosis of PHPT is based on the documentation of elevated serum calcium in 
combination with elevated serum parathyroid hormone (PHT) levels. The initial finding of 
an elevated serum calcium (ionized fraction) level should always raise the suspicion of 
PHPT and in such cases hypercalceamia should be confirmed by a repeat test. In such cases, 
other causes of hypercalcaemia should be excluded (history of vitamin D intake, thiazide 
diuretics and family history of hypercalcemia). Elevated parathyroid hormone levels in the 
presence of persistent hypercalcemia confirms the diagnosis of primary 
hyperparathyroidism. Inorder to eliminate the variations that can occur with respect to time, 
blood volume, and dietary intake the PTH and serum calcium levels should be measured 
simultaneously. 
The first generation parathyroid hormone assays is becoming obsolete. Second-generation 
parathyroid hormone assays (known as 'intact'), and third-generation parathyroid hormone 
assays (known as ‘whole or bio-intact’) are becoming more popular. 
4.2 Additional investigations 
The concentration of serum phosphate varies between 2.5 and 4.5 mg/100ml. About half the 
patients with PHPT have hypo-phosphataemia provided they do not have significant renal 
impairment. Also, 10-40% of patients have elevated levels of serum alkaline phospatase and 
almost all these patients have significant bone invovelment. Imaging studies have no role in 
the diagnosis of primary hyperparathyroidism and are mainly used for localization. 
Recently a new clinical phenotype of PHPT has been identified known as normocalcemic 
PHPT. Eucalcemic primary hyperparathyroidism may represent the earliest manifestation 
of primary hyperparathyroidism. As for now more information is needed on this entity to 
consider its routine evaluation in PHPT (Peacock et al, 2005; Lowe et al, 2007). 
5. The surgical management of PHPT 
Surgery provides the only available cure for primary hyperparathyroidism. Although 
operative management is clearly indicated for all patients with symptomatic PHPT (classic 
symptoms or complications of PHPT), the role of surgery for asymptomatic PHPT is still 
controversial.  
5.1 Decision making: “Current indications and guidelines” 
There is no doubt patients with symptomatic PHPT should undergo surgery as there is 
enough evidence of symptomatic improvement and reversal of the effects of PHPT (such as 
www.intechopen.com
 
Thyroid and Parathyroid Diseases – New Insights into Some Old and Some New Issues 
 
156 
improvement in bone density, reduction in fractures, reduced frequency of kidney stones, 
and improvements in some neurocognitive elements and sense of well being). 
Controversy still exists as whether patients with asymptomatic PHPT should undergo 
surgery. Data increasingly appears to support parathyroidectomy in all patients with PHPT 
because it is associated with a quantifiable improvement in health related quality of life. 
(Sheldon et al, 2002). 
However, among the so called ‘asymptomatic patients’ only about 2-5% are truly 
asymptomatic. Inorder to address this issue and set down guidelines, three conferences 
have been held on the management of asymptomatic PHPT during the past 18 years. The 
most recent conference (the third) was held in 2008 from which summary of guidelines are 
available for reference. Important aspects based on the current guidelines for surgical 
intervention and for medical surveillance, for patients with asymptomatic 
hyperparathyroidism are listed in table 3. (Bilezikian et al, 2009). As for now the surgical 





No Kidney Stones, Nephrocalcinosis, Fractures, Or 
Other Symptoms 
 Age  <50 years 
 Serum Calcium >1 mg/dl Above Normal Upper Limit Of Normal 
 Creatinine Clearance  <60 ml/Min 
 Bone Mineral Density 
(BMD) 
T-Score<-2.5 At Lumbar Spine, Hip, Or Forearm 
 
24 hr Urine Calcium  
Not Indicated (Hypercalciuria By Itself Is Not 
Considered An Indication For Surgery) 
 
Asymptomatic PHPT who 
do not meet above 
criteria(1,2,3,4,5,6) 
Medical surveillance (Can be safely managed 
without surgery) 
Monitor: 
serum calcium levels biannually 
Serum creatinine levels-annually 
BMD 1-2 years at three sites 
Table 3. Current guidelines for surgical management of asymptomatic PHPT  
5.2 Pre-operative localization: “Chasing the target”  
Once we have confirmed the diagnosis of primary hyperparathyroidism from the laboratory 
and clinical information, the next and one of the most important step is to identify the 
source of the disease process.  
In the past the only way of identifying an abnormal gland was at the time of bilateral neck 
exploration and the best tool available was an experienced surgeon!! This is aptly reflected 
in the words of Doppmann “in my opinion, the only localizing study indicated in a patient with 
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The argument was that, in the hands of an experienced parathyroid surgeon, 95%to 97% of 
the cases could be resolved by a single neck exploration. Thus, in the past, the only 
indication for preoperative localization was re-exploration following an unsuccessful 








Cheap & non invasive, no radiation, can localize upto 80% 
of adenomas. 
Not very useful for ectopic parathyroids 
USG guided FNAC can help confirm an adenoma 
preoperatively 






Useful for localizing ectopic glands 
Thin-section contrast-enhanced CT is reported to have a 
sensitivity ranging from 46% to 87%. 




Useful for localizing ectopic glands 




The ‘trend setter’ and breakthrough investigation. 
“The preoperative localization investigation of choice in 
parathyroid disease” 
positive sestamibi does not improve surgical outcome  
Negative sestamibi scan is a predictor of those patients that 
are less likely to be cured.( Allendorf et al,2003) 
Combined with single photon-emission computed 
tomography (SPECT) can localize 90% of adenomas 
including ectopics.( Ho Shon et al,2001) 
 
Combined USG + 
Tc99m Sestamibi 
Scanning 
Ultrasound scan (USG) and Technetium (Tc 99m) sestamibi 
scanning are combined, localization of a parathyroid 
adenoma is accurate in over 95% of cases (Miura et al,2002) 
Allows preoperative skin marking of the parathyroid 
position. 
Table 4. Techniques of preoperative localization. 
The interest in preoperative localization techniques is being given even more importance now, 
as more and more minimal access techniques are being developed for parathyroidectomy. 
Therefore it would be logical if the offending gland could be accurately localized as a part of 
preoperative planning. Preoperative localization would be advantageous for a single gland 
disease, but its utility in multi-gland disease is questionable. At present no single method of 
parathyroid localization matches to the unguided neck exploration by an experienced surgeon.  
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 Preoperative localization studies help plan the operative approach in patients who have 
biochemically confirmed diagnosis of primary hyperparathyroidism. 
 Imaging studies are mainly used for localization and they have no role in the diagnosis. 
 A single site positive imaging result does not rule out the possibility of multiglandular 
disease. 
 Tc-99m sestamibi-SPECT scanning has been shown to be the best imaging modality to 
localize parathyroid adenomas. 
5.3 Parathyroidectomy: “The dawn of a new concept” 
Felix Mandl performed the first successful parathyroidectomy in Vienna in 1925. (Mandl, 
1925). Thereafter and for a considerably long time the standard accepted procedure was 
wide exposure, for bilateral neck exploration and evaluation of all the four parathyroids.  
The surgical treatment for PHPT has undergone a dramatic change in the last decade owing 
to the development of better localization techniques. The standard treatment advocated and 
practiced for years could be considered as a source control operation involving routine 
bilateral exploration of the neck with an attempt to identify and eliminate the offending 
gland or glands. These surgeries were elaborate, time consuming and the success rates 
depended on the experience of the surgeon. When performed by experienced surgeons, cure 
rates with parathyroidectomy are 95% to 98%, and complication rates are 1% to 2%. (Schell 
& Dudley, 2003; Clark, 1997) Of late, certain novel and more patient -friendly techniques 
such as minimally invasive surgery and targeted selective gland excision are being 
performed with reportedly excellent outcomes.  
The present era of ‘minimal access surgery’ has made considerable progress in the field of 
parathyroid surgery too. The recent trend is to develop procedures that require significantly 
smaller incisions for performing the same procedure. The routinely performed parathyroid 
exploration which made use of the large Kocher cervicotomy can be now be conveniently 
referred to as the, ‘conventional’ or ‘standard parathyroidectomy’. Any other surgical 
method or access entailing a smaller incision could therefore be referred to as minimal 
access parathyroidectomy (MAP) or minimally invasive parathyroidectomy (MIP). 
The protocol of bilateral neck exploration was challenged initially in the 1980s, when a 
unilateral approach was advocated in an attempt to avoid the need for contralateral 
exploration and its associated risks (Wang, 1985; Tibblin, et al., 1982; Russell et al., 1990). 
There was a dramatic change in concept following the introduction of Tc99m-sestamibi 
parathyroid scanning especially with reports such as simultaneous sestamibi and 
ultrasound of the neck could localize an enlarged parathyroid gland with almost 95% 
accuracy. The rationale was that if the abnormal parathyroids could be localized 
accurately then they could be appropriately targeted and removed through very small 
incisions, thereby offering the proclaimed advantageous of minimally invasive surgery in 
a general perspective. This thought paved the way for developing minimal-access 
parathyroid surgeries. 
Many studies have shown that minimally invasive parathyroidectomy offers advantages 
like reduced hospital costs, shorter hospital stays, a lower incidence of hypocalcemia, and 
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equally high cure rates with lower complication rates (Udelsman R, 2002; Bergenfelz et al., 
2002; Goldstein et al., 2000). 
An average Kochers collar incision was usually about 8-10cm long. With time surgeons 
learned to perform the conventional bilateral exploration utilizing smaller incisions of about 
4.1 cm (Brunaud et al, 2003). The point at which the procedure becomes a minimal-access 
operation probably is best defined by the length of the incision. It has been suggested that 
the procedure can be referred to as MAP when the inscion length is less than 2.5cm for a 
patient with BMI of less than 30. 
 
Fig. 5. Schematic representation comparing length of incisions of conventional (A) and 
minimally invasive parathyroidectomy (B). 
5.4 Types of minimal access surgeries for parathyroid -“An overview of assortments” 
5.4.1 Unilateral neck exploration (UNE) 
The feasibility of unilateral neck exploration is based on the fact that that 85-90% of patients 
have single gland disease which could be preoperatively accurately localized by 99mTc 
sestamibi scanning and/or ultrasound. Therefore such patients require excision of only one 
gland to achieve a cure. The unilateral approach to the solitary parathyroid adenoma was 
advocated by Wang and later refined by Tibblin et al. 
A meta-analysis of 99mTc sestamibi scanning has revealed a sensitivity and specificity of 
90.7% and 98.8% respectively suggesting that the majority of patients may be suitable for 
unilateral exploration (Denham & Norman, 1998). A prospective randomized trial compared 
unilateral versus bilateral neck exploration in 91 patients. There was no statistically 
significant difference in the incidence of multiglandular disease, costs, or cure rate (95.1% 
vs. 97.5%) between unilateral versus bilateral exploration. However patients who 
underwent unilateral neck exploration had a lower incidence of biochemical and early 
severe symptomatic hypocalcaemia compared to patients who underwent bilateral 
exploration (Bergenfelz et al, 2002). 
www.intechopen.com
 
Thyroid and Parathyroid Diseases – New Insights into Some Old and Some New Issues 
 
160 
In another series of 184 patients who underwent scan-directed UNE, long term cure rates of 
98.4% were reported (Sidhu et al, 2003) 
 
Fig. 6. Chart showing types of minimal access procedures for parathyroidectomy 
5.4.2 Focused parathyoidectomy (FNE)  
Also known as focused neck exploration(FNE). FNE can be performed as a day-case surgery 
and either under general anesthesia, cervical block, local anesthesia and sedation (Agarwal 
et al, 2002). Following 150 MIPs, 74 patients were discharged the same day and a further 70 
were discharged the following day (within 23 h) (Mihai et al, 2007). 
The technique usually makes use of a small (2cm) lateral incision to enter the space between 
the lateral border of the strap muscles and sternomastoid and thereby reach the lateral 
border of the thyroid gland and gain direct access to the parathyroid bearing areas. An FNE 
can be performed in as little as 12 minutes (Delbridge, 2003) and is achieved fully 
maintaining the principles, established with conventional parathyroid surgery.  
Similar conclusions were drawn from a retrospective study comparing 255 focused lateral 
approaches to 401 bilateral neck explorations ,where there was no significant difference in 
surgical success (99% versus 97%) or complication rates (1.2% versus 3%). However a 
favorable reduction in the operating time from 2.4 hours to 1.3 hours for MIP was 
demonstrated. 
As with FNE the obvious advantages are that these explorations are suitable for those 
patients who may otherwise be high risk candidates for general anesthesia.  
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5.4.3 Endoscopic parathyroidectomy / Minimally invasive endoscopic 
parathyroidectomy (MIEP) 
Minimally invasive endoscopic parathyroidectomy (MIEP) is now regarded as a feasible 
surgical procedure. Early work on endoscopic approach to parathyroid disease was first 
described by Gagner. (Gagner, 1996)  
The neck is obviously a small area, and therefore the major technical challenge of an 
endoscopic approach to parathyroidectomy was creation of enough working space to obtain 
adequate exposure and freedom of movement. 
Enthusiasts have tried and tested various approaches including a three-port lateral 
approach along the anterior border of the sternomastoid muscle (Henry et al,1999) to a 
midline suprasternal port and two lateral ports on the same or opposite sides of the neck, in 
front or behind the sternomastoid muscle (Gauger et al, 1999). Irrespective of the port 
placement, the technique is essentially an endoscopic lateral approach. [Figure 7& 8] An 
axillary approach has also been described, inserting three trocars through the axilla. This 
completely avoids any scars in the neck or anterior chest. 
 
Fig. 7. Port positions in endoscopic parathyroidectomy using central access technique 
5.4.4 Minimally invasive videoscopically assisted parathyroidectomy (MIVAP)  
Miccoli P et al developed and described this gaseless procedure in 1998. The localized 
adenoma is approached via a 1.5 cm suprasternal incision, through which 5 mm endoscope 
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is inserted, dissection is carried out with 2 mm spatulas and forceps. The rest of the 
operation follows the standard principles of open parathyroid surgery, with recurrent 
laryngeal nerve (RLN) identification and ligation of the parathyroid vascular pedicle 
MIVAP offers advantages over the endoscopic approach, with the preservation of tactile 
contact and a considerably smaller insicon. 
5.4.5 Minimally invasive radio-guided parathyroidectomy (MIRP) – (gamma probe 
assisted parathyroidectomy) 
A hand held gamma probe is used to determine the position of the incision and guide the 
dissection (20 mCi of Technetium 99msestamibi is injected intravenously, two to four hours 
prior to the surgery) the principle is similar that of sentinel lymph node biopsy.  
 
Fig. 8. Schematic representation of endoscopic parathyroidectomy: lateral access technique  
With the continued improvements in parathyroid imaging techniques, minimally invasive 
parathyroidectomy is rapidly becoming the procedure of choice in patients with PHPT. 
5.4.6 Intra-operative PTH (IOPTH) measurement 
IOPTH measurements were first introduced in 1990, and represent an alternative to four-
gland visualization. (Irvin GL., 1999) This is regarded as an important advancement in the 
development of unilateral surgery, replacing the need for visualisation of all glands, and has 
been referred to as biochemical “frozen section”. During surgery, blood is drawn for PTH 
assays before (baseline) and after the excision of a hyperfunctioning gland. The removal of 
the diseased hyperfunctioning parathyroid tissue is predicted by a fall of PTH by more than 
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50% of its preoperative (baseline ) value, within 10 to 15 minutes. Studies have reported that 
a 50% reduction from pre-excision PTH values within 5-10 minutes of adenoma excision can 
accurately predict post-operative normocalcaemia. (Inabnet et al, 1999). In other words, a 
decrease of more than 50% from the baseline value at 5–10 minutes after resection is 
suggestive of a single gland disease (solitary adenoma). However, if such a drop does not 
occur, then the possibility of multi gland disease is likely, and a conversion to bilateral neck 









Similar complication rates between minmal access 
parathyroidectomy and conventional parathyroidectomy(Starker 
et al 2011) 
Recurrent laryngeal nerve injury and transient 
hypoparathyroidism <1% 
Post operative haemorrhage (0.2%–0.5%) 
 
Cosmesis 
Definitive evidence of smaller scars 
Some opine that centrally placed scars appear better than lateral 
scars 
Concern of central scar more prone to keloid formation 
Axillary approach avoids unsightly scars in visible areas of the 
neck & torso 
 
Hospital stay 
Shorter hospital stay < 23 hrs 
Day case surgery especially if performed under local anaesthesia 
Table 5. Overview of outcomes in minimal access parathyroidectomy 
The disadvantages described include its cost,and interaction with anesthetic drug propofol 
(which should be stopped 5-10 minutes before blood sampling). The full potential of IOPTH 
needs further study. The role of intra-operative radioguided technique is controversial. 
Some are of the opinion that radioguided techniques rarely provide any additional 
information over the sestamibi scan itself and should not be routinely used during parathyroid 
operations. 
All patients may not be candidates for directed or targeted minimal access approaches. 
Patients with mutigland disease, MEN-related hyperplasia, and renal disease may not be 
suitable candidates for MAP. Whether the long term outcomes of MAP will be comparable 
to the best results obtainable with a conventional bilateral exploration remains to be proven. 
KEY POINTS-4 
 Since majority of the patients have only a single-gland disease, bilateral neck 
exploration is not routinely necessary, in all patients. 
 The term MAP/MIP should be reserved for parathyroidectomies performed through 
inscions less than 2.5 cm. 
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 Cure rates are equivalent to those of a bilateral neck exploration for single gland disease. 
 Advantages include avoidance of general aneasthesa and overnight admission, good 
cosmesis. 
 Minimal access approach may be best suited for single adenomatous disease. 
 Surgical expertise is still an important factor. 
6. Conventional parathyroidectomy: “Identification and dissection of the 
parathyroid glands” 
The three important goals in parathyroid surgery are- 
1. Recognizing the normal from abnormal parathyroids. 
2. Identifying and protecting recurrent laryngeal nerves. 
3. Searching for parathyroids in predictable locations. 
The initial operative steps are similar to that for thyroidectomy. The corresponding thyroid 
lobe is elevated and the structures lying under this region are carefully inspected first. The 
normal parathyroids and the fat in this region may appear similar initially and moreover the 
parathyroids may be covered by a globule or layer of adipose tissue. 
 
Fig. 9. Schematic representation of the expected anatomy during conventional 
parathyroidectomy. The thyroid lobe is mobilized .The recurrent laryngeal nerve(RLN) lies 
in the trachea-oesophageal groove. The commonest position of the superior parathyroid 
gland (SP) is posterior to the superior or middle third of the thyroid lobe and that of the 
inferior parathyroid gland(IP) is anterior, lateral, or posterior to the inferior third of the 
thyroid lobe with the nerve passing obliquely between them. 
A small pledget can be used to tease way cobweb like fascia lying in close proximity to the 
posterolateral surface of the elevated thyroid lobe. This will most often bring into view the 
locations of the superior and inferior parathyroids. The presence of globular fat deposits 
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might create some amount of confusion. The normal parathyroids are soft and can be 
present in different shapes and may be sometimes very much flattened like a disc by the 
overlying fascial layer. Once the fascia is teased away the glands will appear to be more 
globular. The gland will also have a network of fine capillaries on the surface [figure 10] and 
a biopsy might cause it to bleed (in contrast to fat). Lymph nodes and thyroid nodules may 
add to confusion too but these are often palpably firm. 
The recurrent laryngeal nerve typically runs in the tracheo–esophageal groove with the 
superior parathyroids more anteriorly and inferior parathyroids more posterior in relation 
to this nerve. Capsular rupture of the abnormal gland should be avoided to prevent 
implantation of parathyroid cells in the operative site. Histological confirmation by frozen 
section examination is often valuable. 
 
Fig. 10. (A) Operative photograph showing the parathyroid (P) which can be differentiated 
from fat (F) by the presence of fine blood vessels on the surface of the gland. (B) Operative 
photograph depicting normal relationships between recurrent laryngeal nerve (RLN), and 
superior(SP) and inferior parathyroid(IP) glands. 
7. Ectopic parathyroids: “The hunt for the elusive parathyroids” 
Sometimes, all the parathyroid glands cannot be identified readily. A systematic search is 
performed; based on the knowledge of the path of descent of superior and inferior 
parathyroid glands. The table gives a brief description of the places to look for in such cases. 
The superior parathyroid glands are normaly located on the posterior aspect of the superior 
or middle third of the thyroid lobe in more than 90% of the cases. The location of an ectopic 
superior parathyroid gland may be above the upper pole of the thyroid lobe (<1%); 
posterior to the pharynx or esophagus, in either the neck or the superior mediastinum (1%–
4%); or intrathyroidal (<3%) (Eslamy & Ziessman, 2008). 
The ectopic inferior parathyroid glands may be found, inferior to the lower pole of the thyroid 
lobe, either in the thyrothymic ligament or associated with the cervical portion of the thymus 
(26%); on or adjacent to the posterior aspect of the middle third of the thyroid lobe (7%); in the 
anterior mediastinum (4%–5%); intrathyroidal (<3%); or along the carotid sheath (<1%–2%).  
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Gland Where to look for 
Superior parathyroids 
adjacent to the superior thyroid vessels 
the carotid sheath or posterior to the 
esophagus or pharynx (retroesophageal) 






capsule of the thyroid 
Table 7. Locations of ectopic parathyroid s 
 
Fig. 11.  
8. Conclusion - “The future” 
As the patients are often asymptomatic, the diagnosis of primary hyperparathyroidism is 
based principally on laboratory findings of elevated serum calcium and serum parathyroid 
hormone levels. Asymptomatic disease is the commonest form of presentation in the 
developed nations. Symptomatic disease is very common in developing parts of the world. 
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Surgery is the only, definitive treatment for symptomatic disease. Since majority of cases of 
primary hyperparathyroidism, are due to a single parathyroid adenoma, selective gland 
excision is a better option. This should be facilitated with appropriate preoperative 
localization techniques such as with (Tc99m) sestamibi scanning alone or combined with 
other modalities wherever possible. Intra-operative parathyroid hormonal monitoring may 
be a useful adjunct and can predict possibility of multigland disease and the need for 
converting the procedure to a bilateral neck exploration. The new surgical procedures are 
here to stay. Minimally access parathyroid surgery is feasible and should probably be 
increasingly offered to select group of patients. Conversion to bilateral neck exploration 
should not be regarded as a complication.  
The final statement is that: “the success of both conventional and minimal access 
parathyroidectomy is dependent on the surgeon’s hard earned experience and nothing can 
substitute that. “ 
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